Controlled Stimulus-Responsive Delivery Systems for Osteoarthritis Treatment

Area of Science:

• Biomaterials Science
• Nanotechnology
• Rheumatology
• Drug Delivery Systems

Background:

• Osteoarthritis (OA) is a prevalent, disabling degenerative joint disease causing significant patient and societal burden.
• Articular cartilage degradation and inflammation are key to OA pathogenesis, but cartilage's limited healing capacity necessitates advanced treatments.
• Current OA treatments are insufficient, highlighting the need for effective therapeutic strategies.

Purpose of the Study:

• To review and discuss advancements in delivery systems for osteoarthritis (OA) treatment.
• To focus on stimuli-responsive release mechanisms for precision OA therapy.
• To explore the application of various delivery systems in targeting cartilage and chondrocytes.

Main Methods:

• Review of current delivery systems including nanoparticles, hydrogels, liposomes, and microspheres.
• Analysis of endogenous stimuli-responsive release (redox, pH, enzymes, temperature).
• Analysis of exogenous stimuli-responsive release (near-infrared, magnetic, ultrasound).

Main Results:

• Delivery systems demonstrate promise for intra-articular drug administration in OA.
• Stimuli-responsive systems offer prolonged joint retention and targeted delivery to cartilage or chondrocytes.
• Both endogenous and exogenous stimuli can be harnessed for controlled drug release in OA treatment.

Conclusions:

• Intra-articular delivery systems represent a promising approach for precision osteoarthritis therapy.
• Stimuli-responsive release mechanisms are crucial for enhancing therapeutic efficacy and targeting.
• Further development of nano-delivery systems is needed to address current challenges in OA treatment.